Endo Tools Therapeutics Appoints Devon Bream as Chief Executive Officer

Endo Tools Therapeutics Appoints Devon Bream as Chief Executive Officer Leadership transition positions ETT for its next phase of commercial growth and physician adoption   Gosselies, Belgium – July 22, 2026 – Endo Tools Therapeutics (ETT), developers of advanced endoscopic medical devices, today announced the appointment of Devon Bream, MPH, FACHE, as Chief Executive Officer. […]

Endo Tools Therapeutics Secures $23 million in Series C Financing to Advance The endomina® technology and Commercialization of New endomina EZFuse System

Endo Tools Therapeutics Secures $23 million in Series C Financing to Advance The endomina® technology and Commercialization of New endomina EZFuse System Funding to accelerate U.S., European and Middle East commercialization and collect clinical evidence for U.S. weight loss marketing indication Gosselies, Belgium – July 16th, 2026 – Endo Tools Therapeutics (ETT), developers of advanced […]

Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation Endomina® EZFuse system 

Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation Endomina® EZFuse system   510(k) clearance enables immediate U.S. commercialization of enhanced soft tissue approximation technology in the gastrointestinal tract   Gosselies, Belgium – March 17, 2026 – Endo Tools Therapeutics (ETT), developers of advanced endoscopic medical devices, today announced that the U.S. Food and Drug Administration (FDA) has […]

Please confirm your location. Content for healthcare professionals only.

Europe and Middle East
US